TW200734295A - Alkyl-resorcinol glycoside, process for production of the same, and use of the same - Google Patents

Alkyl-resorcinol glycoside, process for production of the same, and use of the same

Info

Publication number
TW200734295A
TW200734295A TW095148800A TW95148800A TW200734295A TW 200734295 A TW200734295 A TW 200734295A TW 095148800 A TW095148800 A TW 095148800A TW 95148800 A TW95148800 A TW 95148800A TW 200734295 A TW200734295 A TW 200734295A
Authority
TW
Taiwan
Prior art keywords
same
alkylresorcinol
glycoside
resorcinol
alkyl
Prior art date
Application number
TW095148800A
Other languages
Chinese (zh)
Inventor
Takashi Shibuya
Ayashi Noguchi
Satoru Takayama
Yasuo Suemoto
Makoto Takeuchi
Masayuki Nakano
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of TW200734295A publication Critical patent/TW200734295A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Abstract

The object is to provide a 4-alkylresorcinol derivative in which defects inherent to a 4-alkylresorcinol are overcome and which is excellent in solubility in water and stability, has substantially no taste and no odor, is not irritative, is free from the concern about toxicity, and can exert its physiological activity in a living body satisfactorily. Thus, disclosed is a 4-alkylresorcinol glycoside which has a glycosyl group attached to one or both of the hydroxyl groups in a 4-alkylresorcinol.
TW095148800A 2005-12-26 2006-12-25 Alkyl-resorcinol glycoside, process for production of the same, and use of the same TW200734295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005373040 2005-12-26

Publications (1)

Publication Number Publication Date
TW200734295A true TW200734295A (en) 2007-09-16

Family

ID=38228125

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095148800A TW200734295A (en) 2005-12-26 2006-12-25 Alkyl-resorcinol glycoside, process for production of the same, and use of the same

Country Status (3)

Country Link
JP (2) JP5244400B2 (en)
TW (1) TW200734295A (en)
WO (1) WO2007077770A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021031594A1 (en) * 2019-08-21 2021-02-25 云南巅青生物科技有限公司 Aromatic ring compound

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288537B2 (en) * 2008-03-03 2013-09-11 国立大学法人広島大学 Novel bioactive composition
TWI414317B (en) * 2008-05-29 2013-11-11 Shiseido Co Ltd External preparation for skin
KR102527742B1 (en) * 2008-07-21 2023-04-28 유니젠, 인크. Series of skin-whitening (lightening) compounds
JP2010150240A (en) * 2008-11-20 2010-07-08 Oppen Keshohin Kk External preparation for skin, anti-inflammatory agent, whitening agent and cosmetic making nigerooligosaccharide as active ingredient
JP6589857B2 (en) 2014-04-02 2019-10-16 日本ゼオン株式会社 Method for producing positive electrode for lithium ion secondary battery provided with electrolytic solution
CN115554180B (en) * 2022-10-24 2023-09-22 陕西畅想制药有限公司 4-butylresorcinol supermolecule vesicle aggregate, preparation method thereof and cosmetic composition
CN116217754A (en) * 2023-01-31 2023-06-06 上海贤鼎生物科技有限公司 4-alkyl resorcinol cyclodextrin derivative supermolecule, preparation method thereof and application thereof in preparing cosmetics

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056994A (en) * 1983-09-08 1985-04-02 Sunstar Inc Tocopherol derivative
JPH0651619B2 (en) * 1988-05-09 1994-07-06 株式会社クラレ Whitening agent
JPH09241128A (en) * 1996-03-01 1997-09-16 Nippon Paint Co Ltd Agent for inhibiting activity of tyrosinase
BR9803596A (en) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivatives of resorcinol.
JP2000128762A (en) * 1998-10-28 2000-05-09 Kose Corp Melanogenesis inhibitor and skin preparation for external use for beautifying containing the same
JP2001206837A (en) * 1999-11-18 2001-07-31 Noevir Co Ltd Skin preparation for external use
JP2001206813A (en) * 2000-01-27 2001-07-31 Pola Chem Ind Inc Skin preparation for external use for physical therapy
JP4615671B2 (en) * 2000-04-20 2011-01-19 ポーラ化成工業株式会社 Preventing wrinkle formation or loss of skin elasticity for use in the presence of inflammation
JP2002193990A (en) * 2000-12-25 2002-07-10 Mitsui Chemicals Inc Hydrochalcone glycoside and cosmetic formulated with the same as effective component
JP2003160461A (en) * 2001-11-21 2003-06-03 Shiseido Co Ltd Skin care preparation
JP2004115381A (en) * 2002-09-24 2004-04-15 Shiseido Co Ltd External preparation for skin
JP2004131388A (en) * 2002-10-08 2004-04-30 Shiseido Co Ltd Skin care preparation for external use
JP4568488B2 (en) * 2003-09-05 2010-10-27 花王株式会社 Isopropylmethylphenol glycoside
JP2005120023A (en) * 2003-10-16 2005-05-12 Shiseido Co Ltd Skin care preparation
JP2005336113A (en) * 2004-05-27 2005-12-08 Kao Corp Skin cosmetic
JP2006124357A (en) * 2004-11-01 2006-05-18 Shiseido Co Ltd 4-alkylresorcinol derivative and bleaching agent containing the same as active ingredient

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021031594A1 (en) * 2019-08-21 2021-02-25 云南巅青生物科技有限公司 Aromatic ring compound

Also Published As

Publication number Publication date
JP2013129658A (en) 2013-07-04
WO2007077770A1 (en) 2007-07-12
JPWO2007077770A1 (en) 2009-06-11
JP5244400B2 (en) 2013-07-24

Similar Documents

Publication Publication Date Title
TW200734295A (en) Alkyl-resorcinol glycoside, process for production of the same, and use of the same
CY1118984T1 (en) PREPARATION OF ACTIVE, HIGHLY PHOSPHORYLATED, HUMAN LYSOSOMIC SULFATASE ENZYMES AND USES THEREOF
UA91848C2 (en) Diosmetin derivatives for the treatment and prevention of thrombotic pathologies
MX2011009539A (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof.
MY148405A (en) Immunogenic composition
MXPA05009015A (en) Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament.
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
MX273164B (en) Process for preparing hydrocolloids.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
PT1928882E (en) (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use
MY142067A (en) Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease
PT1771178E (en) Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies
WO2005077093A3 (en) Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
TW200736213A (en) Dicarboxylic acid derivatives and their use
WO2006099941A8 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
UY31305A1 (en) DERIVATIVES OF 1,2,4,5-TETRAHIDRO-3H-BENZAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
TW200724532A (en) Pyrimidinecarboxylic acid derivatives and their use
WO2009120919A3 (en) Fenofibrate dosage forms
MX2010001849A (en) Cyclic depsipeptides.
JO2682B1 (en) 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof
CL2012000051A1 (en) Process to produce chitosan derivative by activating chitosan or a chitin which comprises suspending the chitosan in an alcohol / water, stirring for a period of time and subsequently reacting the chitosan or activated precursor with a reagent capable of forming complexes through physical forces or chemicals.
UY29859A1 (en) DERIVATIVES OF 1-AMINO-ISIQUINOLINE, ITS PREPARATION AND THERAPEUTIC APPLICATION
IL187001A0 (en) Preparation of (s)-4-fluromethyl-dihydro-furan -2-one
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments